Anti-B-cell monoclonal antibody treatment of severe posttransplant B- lymphoproliferative disorder: Prognostic factors and long-term outcome

Blood

Volumn 92, Issue 9, 1998, Pages 3137-3147

  Benkerrou, Malika ^a   Jais, Jean Philippe ^b   Leblond, Véronique ^b   Durandy, Anne ^b   Sutton, Laurent ^b   Bordigoni, Pierre ^b   Gamier, Jane Luce ^b   Bidois, Jérôme Le ^b   Deist, Françoise Le ^b   Blanche, Stéphane ^b   Fischer, Alain ^b  

^a HÔPITAL NECKER ENFANTS MALADES   (France)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

B LYMPHOCYTE ANTIBODY; CD24 ANTIGEN; COMPLEMENT COMPONENT C3D RECEPTOR; MONOCLONAL ANTIBODY;

ADOLESCENT; ADULT; ARTICLE; B LYMPHOCYTE; BONE MARROW TRANSPLANTATION; CANCER IMMUNOTHERAPY; CANCER SURVIVAL; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; FEMALE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INTRAVENOUS DRUG ADMINISTRATION; LYMPHOPROLIFERATIVE DISEASE; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; PROGNOSIS; RELAPSE; TREATMENT OUTCOME;

EID: 0032211189     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v92.9.3137     Document Type: Article

References (61)

1. Frizzera G, Hanto DW, Gajl-Peczalska KJ, Rosai J, McKenna RW, Sibley RK, Holahan KP, Lindquist LL: Polymorphic diffuse B-cell hyperplasias and lymphomas in renal transplant recipients. Cancer Res 41:4262, 1981
2. Schubach WH, Hackman R, Neiman PE, Miller G, Thomas ED: A monoclonal immunoblastic sarcoma in donor cells bearing Epstein-Barr virus genomes following allogenic marrow grafting for acute lymphoblastic leukemia. Blood 60:180, 1982
3. Hanto DW, Najarian JS: Advances in the diagnosis and treatment of EBV-associated lymphoproliferative diseases in immunocompromised hosts. J Surg Oncol 30:215, 1985
4. Nalesnik MA, Jaffe R, Starzl TE, Demetris AJ, Porter K, Burnham JA, Makowka L, Ho M, Locker J: The pathology of posttransplant lymphoproliferative disorders occurring in the setting of ciclosporine A-prednisone immunosuppression. Am J Pathol 133:173, 1988
5. Cleary ML, Nalesnik MA, Shearer WT, Sklar J: Clonal analysis of transplant-associated lymphoproliferations based on the structure of the genomic termini of the Epstein-Barr virus. Blood 72:349, 1988
6. Katz B, Raab-Traub N, Miller G: Latent and replicating forms of Epstein-Barr virus DNA in lymphomas and lymphoproliferative diseases. J Infect Dis 160:589, 1989
7. D'Amore ESG, Manivel C, Gajl-Peczalska KJ, Litz CE, Copen- haver CM, Shapiro RS, Strickler JG: B-cell lymphoproliferative disorders after bone marrow transplant. An analysis of ten cases with emphasis on Epstein-Barr virus detection by in situ hybridization. Cancer 68:1285, 1991
8. Kieff E: Epstein-Barr virus and its replication, in Fields BN, Knipe DM, Howley PM, Chanock RM, Molnick JL, Monath TP, Roisman B, Strauss SE (eds): Fields Virology. Philadelphia, PA, Lippincott-Raven, 1996, p 2343
9. Rickinson AB, Kieff E: Epstein-Barr virus, in Fields BN, Knipe DM, Howley PM, Chanock RM, Molnick JL, Monath TP, Roisman B, Strauss SE (eds): Fields Virology. Philadelphia, PA, Lippincott-Raven, 1996, p 2397
10. Papadopoulos EB, Ladanyi M, Emanuel D, Mackinnon S, Boulad F, Carabasi MH, Castro-Malspina H, Childs BH, Gillio AP, Small TN, Young JW, Kernan NA, O'Reilly RJ: Infusions of donor leukocytes to treat Epstein-Barr virus-associated lymphoproliferative disorders after allogenic bone marrow transplantation. N Engl J Med 330:1185, 1994
11. Lucas KG, Small TN, Heller G, Dupont B, O'Reilly RJ: The development of cellular immunity to Epstein-Barr virus after allogenic bone marrow transplantation. Blood 87:2594, 1996
12. Cen H, Williams PA, McWilliams HP, Breinig MC, Ho M, McKnighl JL: Evidence for restricted Epstein-Barr virus latent gene expression and anti-EBNA antibody response in solid organ transplant recipients with posttransplant lymphoproliferative disorders. Blood 81:1393, 1993
13. Rowe M, Young LS, Crocker J, Stokes H, Henderson S, Rickinson AB: Epstein-Barr virus (EBV)-associated lymphoproliferative disease in the SCID mouse model: Implications for the pathogenesis of EBV-positive lymphoma in man. J Exp Med 173:147, 1991
14. Durandy A, Brousse N, Rosenberg F, de Saint-Basile G, Fischer A-M, Fischer A: Control of human B cell tumor growth in severe combined immunodeficiency mice by monoclonal anti-B cell antibodies. Clin Invest 90:945, 1992
15. Zutter MM, Martin PJ, Sale GE, Shulman HM, Fisher L, Thomas ED, Durnam DM: Epstein-Barr virus lymphoproliferation after bone marrow transplantation. Blood 72:520, 1988
16. Fischer A, Landais P, Friedrich W, Gerritsen B, Fasth A, Porta F, Vellodi A, Benkerrou M, Cavazzana-Calvo M, Souillet G, Bordigoni P, Morgan G, Van Dijken P, Vossen J, Locatelli F, Di Bartolomeo P: Bone marrow transplantation in Europe for primary immunodeficiencies other than severe combined immunodeficiency: An EBMT/EGID report. Blood 83:1149, 1994
17. Thomas JA, Hotchin NA, Allday MJ, Amlot P, Rose M, Yacoub M, Crawford DH: Immunohistology of Epstein-Barr virus-associated antigens in B cell disorders from immunocompromised individuals. Transplantation 49:944, 1990
18. Ambinder R, Mann R: Detection and characterization of Epstein-Barr virus in clinical specimens. Am J Pathol 149:235, 1994
19. Starzl TE, Nalesnik MA, Porter KA, Ho M, Iwatsuki S, Griffith BP, Rosenthal JT, Hakala TR, Shaw BW Jr, Hardesty RL, Atchison RW, Jaffe R, Bahnson HT: Reversibility of lymphomas and lymphoproliferative lesions developing under ciclosporine-steroid therapy. Lancet 1:583, 1984
20. Hanto DW, Frizzera G, Gajl-Peczalska KJ, Simmons R: Epstein-Barr virus, immunodeficiency, and B cell lymphoproliferation. Transplantation 39:461, 1985
21. Malatack JJ, Gartner JC, Urbach AH, Zitelli BJ: Orthopic liver transplantation, Epstein-Barr virus, cyclosporine and lymphoproliferative disease: A growing concern. J Pediatr 118:667, 1991
22. Cohen JI: Epstein-Barr virus lymphoproliferative disease associated with acquired immunodeficiency. Medicine 70:137, 1991
23. Sokal E, Carogiozoglou T, Lamy M, Reding R, Otte JB: Epstein-Barr virus serology and Epstein-Barr virus-associated lymphoproliferative disorders in pediatric liver transplant recipients. Transplantation 56:1394, 1993
24. Swinnen LJ, Costanzo-Nordin MR, Fisher SG, O'Sullivan EJ, Johnson MR, Heroux AL, Dizikes GJ, Pifarre R, Fisher RI: Increased incidence of lymphoproliferative disorder after immunosuppression with the monoclonal antibody OKT3 in cardiac-transplant recipients. N Engl J Med 323:1723, 1990
25. Rhandawa PS, Jaffe R, Demetris AJ, Nalesnik M, Starzl TE, Chen YY, Weiss LM: Expression of Epstein-Barr virus-encoded small RNA (by the EBER-1 gene) in liver specimens from transplant recipients with post-transplantation lymphoproliferative disease. N Engl J Med 327:1710, 1992
26. Armitage JM, Kurland G, Michaels M, Cipriani LA, Griffith BP, Fricker FJ: Critical issues in pediatric lung transplantation. J Thorac Cardiovasc Surg 109:60, 1995
27. Grant D: The International Intestinal Transplant Registry: Current results of intestinal transplantation. Lancet 347:1801, 1996
28. Langnas AN, Shaw Jr BW, Antonson DL, Kaufman SS, Mack DR, Heffron TG, Fox U, Vanderhoof JA: Preliminary experience with intestinal transplantation in infants and children. Pediatrics 97:443, 1996
29. Shapiro RS, McClain K, Frizzera G, Gajl-Peczalska KJ, Kersey JH, Blazar BR, Arthur DC, Patton DF, Greenberg JS, Burke B, Ramsay NKC, McGlave P, Filipovitch AH: Epstein-Barr virus associated B cell lymphoproliferative disorders following bone marrow transplantation. Blood 71:1234, 1988
30. Ho M, Jaffe, Miller G, Breinig MK, Dummer JS, Makowka L, Atchinson RW, Karrer F, Nalesnik MA, Starzl TE: The frequency of Epstein-Barr virus infection and associated lymphoproliferative syndrome after transplantation and its manifestations in children. Transplantation 45:719, 1988
31. Ash RC, Casper JT, Chitambar CR, Hansen R, Bunin N, Truitt RL, Lawton C, Murray K, Hunter J, Baxter-Lowe LA, Gottschall JI, Oldham K, Anderson T, Camitta B, Menitove J: Successful allogeneic transplantation of T-cell-depleted bone marrow from closely HLA-matched unrelated donors. N Engl J Med 322:485, 1990
32. Garett TJ, Chadburn A, Barr ML, Drusin RE, Chen JM, Schulman LL, Smith CR, Reison DS, Rose EA, Michler RE, Knowles DM: Posttransplantation lymphoproliferative disorders treated with cyclophosphamide-doxorubicin-vincristine-prednisone chemotherapy. Cancer 72:2782, 1993
33. Shapiro RS, Chauvenet A, McGuire W, Pearson A, Craft AW, McGlave P, Filipovitch A: Treatment of B-cell lymphoproliferative disorders with interferon alfa and intravenous gamma globulin. N Engl J Med 318:1334, 1988 (letter)
34. Hanto DW, Frizzera G, Gajl-Peczalaska KJ, Balfour HH, Simmons RL, Najarian JS: Acyclovir therapy of Epstein-Barr virus induced post-transplant lymphoproliferative diseases. Transplant Proc 17:89, 1985 (abstr)
35. Pirsch JD, Stratta RJ, Sollinger HW, Hafez GR, D'Allessandro AM, Kalayoglu M, Belzer FO: Treatment of severe Epstein-Barr virus-induced lymphoproliferative syndrome with ganciclovir: Two cases after solid organ transplantation. Am J Med 86:241, 1989
36. Rooney CM, Smith CA, Ng CYG, Loftin S, Li C, Krance RA, Brenner MK, Heslop HE: Use of gene-modified virus-specific T lymphocytes to control Epstein-Barr-virus-related lymphoproliferation. Lancet 345:9, 1995
37. Blanche S, Le Deist F, Veber F, Lenoir G, Fischer A-M, Brochier J, Boucheix C, Delaage M, Griscelli C, Fischer A: Treatment of severe Epstein-Barr virus-induced polyclonal B-lymphocyte proliferation by anti-B-cell monoclonal antibodies. Two cases after HLA-mismatched bone marrow transplantation. Ann Intern Med 108:199, 1988
38. Fischer A, Blanche S, Le Bidois J, Bordigoni P, Gamier J-L, Niaudet P, Morinet F, Le Deist F, Fischer A-M, Griscelli C, Hirn M: Anti-B-cell monoclonal antibodies in the treatment of severe B-cell lymphoproliferative syndrome following bone marrow and organ transplantation. N Engl J Med 324:1451, 1991
39. Leblond V, Sutton L, Dorent R, Davi F, Bilker MO, Gabarre J, Charlotte F, Ghoussoub JJ, Fourcade C, Fischer A, Gandjbakhch I, Binet JL, Raphael M: Lymphoproliferative disorders after organ transplantation: A report of 24 cases observed in a single center. J Clin Oncol 13:961, 1995
40. Chebil M, Martin X, Friaa S, Ezzeddine W, Garnier JL, Desmettre O, Marechal JM, Gelet A, Dubernard JM: Lymphoma with bladder involvment and renal transplantation. Prog Urol 5:102, 1995
41. Jarry A, Cerf-Bensussan N, Brousse N, Guy-Grand D, Muzeau F, Potet F: Same peculiar subset of HML-1(+) lymphocytes present within normal intestinal epithelium is associated with tumor epithelium of gastrointestinal carcinomas. Gut 29:1632, 1988
42. Fischer AM, Simon F, Le Deist F, Blanche S, Griscelli C, Fischer A: Prospective study of the occurrence of monoclonal gammapathies following bone marrow transplantation in young children. Transplantation 49:731, 1990
43. Fermand J-P, Gozlan J, Bendelac A, Delauche-Cavallier M-C, Brouet J-C, Morinet F: Detection of Epstein-Barr virus in epidermal skin lesions of an immunocompromised patient. Ann Intern Med 112:511, 1990
44. Rosenberg F, Lebon P: Amplification and characterisation of herpes virus DNA in cerebrospinal fluid from patients with acute encephalitis. J Clin Microbiol 29:2412, 1991
45. Peto R, Picke MC, Armitage P, Breslow NE, Cox DR, Howard SV, Mantel N, McPherson K, Peto J, Smith PG: Design and analysis of randomized clinical trials requiring prolonged observation of each patient-part II: Analysis and examples. Br J Cancer 35:1, 1977
46. Hosmer DW, Lemeshow S: Applied Logistic Regression. New York, NY, Wiley, 1989
47. Kalbfleisch JD, Prentice RL: The Statistical Analysis of Failure Time Data. New York, NY, Wiley, 1980
48. Fischer A, Griscelli C, Friedrich W, Kubanck B, Levinsky R, Morgan G, Vossen J, Wagemaker G, Landais P: Bone marrow transplantation for immunodeficiencies and osteopetrosis: European survey, 1968-1985. Lancet 2:1080, 1986
49. Hanto DW, Frizzera G, Gajl-Peczalska KJ, Sakamoto K, Purtilo DT, Balfour HH, Simmons RL, Najarian JS: Epstein-Barr virus-induced B-cell lymphoma after renal transplantation. N Engl J Med 306:913, 1982
50. Sullivan JL, Medveczky P, Forman SJ, Baker SM, Monroe JE, Mulder C: Epstein-Barr virus-induced lymphoproliferation: Implications for antiviral chemotherapy. N Engl J Med 311:1163, 1984
51. Morrisson VA, Dunn DL, Manivel JC, Gajl-Peczalska KJ, Peterson BA: Clinical characteristics of post-transplant lymphoproliferative disorders. Am J Med 97:14, 1994
52. Knowles DM, Cesarman E, Chadburn A, Frizzera G, Chen J, Rose EA, Michler RE: Correlative morphologic and molecular genetic analysis demonstrates three distinct categories of posttransplantation lymphoproliferative disorders. Blood 85:552, 1995
53. Kingma DW, Weiss WB, Jaffe ES, Kumar S, Frekko K, Raffeld M: Epstein-Barr virus latent membrane protein-1 oncogene deletions correlations with malignancy in Esptein-Barr virus-associated lymphoproliferative disorders and malignant lymphomas. Blood 88:242, 1996
54. Smir BN, Hanke RJ, Bierman PJ. Gross TG, d'Amore F, Anderson JR, Greiner TC: Molecular epidemiology of deletions and mutations of the latent membrane protein 1 oncogene of the Epstein-Barr virus in post transplant lymphoproliferative disorders. Lab Invest 75:575, 1996
55. Murray PG, Swinnen LJ, Constandinou CM, Pyle JM, Carr TJ, Hardwick JM, Ambinder RF: Bcl-2 but not its Epstein-Barr virus-encoded homologue, BHRF1, is commonly expressed in post transplantation lymphoproliferative disorders. Blood 87:706, 1996
56. Antoine C, Gamier JL, Duboust A, Bariety J, Stevenson G, Glotz D: Successful treatment of post-transplant lymphoproliferative disorder with renal graft preservation by monoclonal antibody therapy. Transplant Proc 28:2825, 1996
57. Maloney D, Lices T, Czerwinski D, Waldichiuk C, Rosenberg J, Grillo-Lopez A, Levy R: Phase I clinical trial using escalating single dose infusion of chimeric anti-CD20 monoclonal antibody (IDEC-C2B8) in patients with recurrent B cell lymphoma. Blood 84:2457, 1994
58. Yokoi T, Miyawaki T, Yachie A, Kato Y, Kasahara Y, Taniguchi N: Epstein-Barr virus-immortalized B cells produce IL-6 as an autocrine growth factor. Immunology 70:100, 1990
59. Durandy A, Emilie D, Peuchmaur M, Forveille M, Clement C, Widjenes J, Fischer A: Role of IL-6 in promoting growth of human EBV-induced B-cell tumors in severe combined immunodeficient mice. J Immunol 152:5361, 1994
60. Heslop HE, Ng CY, Li C, Smith CA, Loftin SK, Krance RA, Brenner MK, Rooney CM: Long term restoration of immunity against Epstein-Barr virus infection by adoptive transfer of gene-modified virus-specific T lymphocytes. Nat Med 2:551, 1996
61. Cavazzana-Calvo M, Jabado N, Haddad E, Bensussan D, Brockmeyer C, Fischer A: Ex vivo B and T lymphocyte depletion of partially incompatible marrow graft. Blood 88:420a, 1996 (abstr, suppl 1)